Focused Investors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-688,658
| Closed | -$84.9M | – | 25 |
|
|
2021
Q4 | $84.9M | Buy |
688,658
+66,023
| +11% | +$8.64M | 2.6% | 20 |
|
|
2021
Q3 | $88.5M | Sell |
622,635
-22,557
| -3% | -$3.32M | 2.95% | 20 |
|
|
2021
Q2 | $101M | Sell |
645,192
-140,492
| -18% | -$22.8M | 3.21% | 18 |
|
|
2021
Q1 | $122M | Sell |
785,684
-40,067
| -5% | -$6.21M | 4.23% | 9 |
|
|
2020
Q4 | $124M | Sell |
825,751
-1,133
| -0.1% | -$160K | 4.47% | 8 |
|
|
2020
Q3 | $109M | Sell |
826,884
-22,866
| -3% | -$2.99M | 4.47% | 8 |
|
|
2020
Q2 | $98.5M | Sell |
849,750
-6,695
| -0.8% | -$771K | 4.42% | 10 |
|
|
2020
Q1 | $84M | Sell |
856,445
-54,899
| -6% | -$7.2M | 4.2% | 11 |
|
|
2019
Q4 | $132M | Sell |
911,344
-30,900
| -3% | -$4.27M | 5.25% | 8 |
|
|
2019
Q3 | $126M | Sell |
942,244
-167,375
| -15% | -$21.6M | 5.5% | 9 |
|
|
2019
Q2 | $127M | Sell |
1,109,619
-38,316
| -3% | -$4.49M | 5.56% | 7 |
|
|
2019
Q1 | $142M | Sell |
1,147,935
-37,389
| -3% | -$4.25M | 6.22% | 4 |
|
|
2018
Q4 | $119M | Sell |
1,185,324
-53,663
| -4% | -$6.03M | 5.48% | 8 |
|
|
2018
Q3 | $158M | Sell |
1,238,987
-3,708
| -0.3% | -$441K | 6.22% | 4 |
|
|
2018
Q2 | $134M | Buy |
1,242,695
+4,120
| +0.3% | +$448K | 5.76% | 5 |
|
|
2018
Q1 | $131M | Sell |
1,238,575
-38,625
| -3% | -$4.49M | 5.74% | 6 |
|
|
2017
Q4 | $150M | Buy |
1,277,200
+119,995
| +10% | +$13.6M | 6.08% | 5 |
|
|
2017
Q3 | $132M | Sell |
1,157,205
-34,196
| -3% | -$3.95M | 5.58% | 4 |
|
|
2017
Q2 | $149M | Sell |
1,191,401
-284,898
| -19% | -$33.8M | 6.31% | 1 |
|
|
2017
Q1 | $175M | Buy |
1,476,299
+278,203
| +23% | +$31.5M | 6.32% | 1 |
|
|
2016
Q4 | $120M | Buy |
1,198,096
+318,579
| +36% | +$34.1M | 4.56% | 13 |
|
|
2016
Q3 | $111M | Sell |
879,517
-8,446
| -1% | -$1.04M | 4.41% | 10 |
|
|
2016
Q2 | $104M | Sell |
887,963
-14,935
| -2% | -$1.69M | 4.09% | 13 |
|
|
2016
Q1 | $93.5M | Sell |
902,898
-28,222
| -3% | -$2.73M | 3.59% | 12 |
|
|
2015
Q4 | $92.7M | Sell |
931,120
-73,542
| -7% | -$7.2M | 3.58% | 16 |
|
|
2015
Q3 | $91.6M | Buy |
1,004,662
+370,388
| +58% | +$37.1M | 3.35% | 16 |
|
|
2015
Q2 | $67.3M | Sell |
634,274
-4,326
| -0.7% | -$479K | 2.33% | 22 |
|
|
2015
Q1 | $72.9M | Buy |
638,600
+19,982
| +3% | +$2.28M | 2.52% | 21 |
|
|
2014
Q4 | $68.1M | Sell |
618,618
-39,243
| -6% | -$4.14M | 2.47% | 21 |
|
|
2014
Q3 | $64.2M | Sell |
657,861
-4,120
| -0.6% | -$405K | 2.36% | 23 |
|
|
2014
Q2 | $66.8M | Sell |
661,981
-3,605
| -0.5% | -$352K | 2.5% | 22 |
|
|
2014
Q1 | $61.1M | Sell |
665,586
-21,527
| -3% | -$1.98M | 2.42% | 22 |
|
|
2013
Q4 | $62.2M | Sell |
687,113
-515
| -0.1% | -$44.6K | 2.44% | 22 |
|
|
2013
Q3 | $54.8M | Buy |
687,628
+25,235
| +4% | +$1.99M | 2.36% | 23 |
|
|
2013
Q2 | $48.2M | Buy |
+662,393
| New | +$49.5M | 2.09% | 24 |
|
Other funds holding ZBH
Focused Investors's ZBH Position: Q1 2022 in Review
Focused Investors sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 688,658 shares — an estimated $84.9M sold.
Focused Investors first reported a position in ZBH in Q2 2013 and held it in 35 quarters. The position peaked at $175M in Q1 2017. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.
- Focused Investors reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
- Focused Investors sold 688,658 Zimmer Biomet shares in Q1 2022, an estimated $84.9M.
- Focused Investors first reported a position in Zimmer Biomet in Q2 2013 and held it in 35 quarters.
- Focused Investors's Zimmer Biomet position peaked at $175M in Q1 2017.
- 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.
Based on Focused Investors's 13F filing for Q1 2022, filed 20 Apr 2022.